These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 34814419)

  • 21. Risk factor compositions of nonalcoholic fatty liver disease change with body mass index in males and females.
    Wang L; Guo J; Lu J
    Oncotarget; 2016 Jun; 7(24):35632-35642. PubMed ID: 27248665
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Body mass index is a risk factor for new-onset non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus].
    Wang S; Zhang H; Tong B; Wang Q; Zhang Y; Zhu G; Wu S
    Zhonghua Gan Zang Bing Za Zhi; 2015 Oct; 23(10):754-9. PubMed ID: 26573192
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IMPACT OF TYPE 2 DIABETES ON NONALCOHOLIC STEATOHEPATITIS AND ADVANCED FIBROSIS IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE.
    Bian H; Zhu X; Xia M; Yan H; Chang X; Hu X; Pan B; Guo W; Li X; Gao X
    Endocr Pract; 2020 Apr; 26(4):444-453. PubMed ID: 31968197
    [No Abstract]   [Full Text] [Related]  

  • 24. [Risk factors analysis of nonalcoholic fatty liver disease in Chinese men].
    Zheng RD; Zhuang QY; Chen JN; Chen J; Lu YH
    Zhonghua Gan Zang Bing Za Zhi; 2013 Jan; 21(1):62-5. PubMed ID: 23663766
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The bidirectional relationship between NAFLD and type 2 diabetes: A prospective population-based cohort study.
    Wang M; Zhao Y; He Y; Zhang L; Liu J; Zheng S; Bai Y
    Nutr Metab Cardiovasc Dis; 2023 Aug; 33(8):1521-1528. PubMed ID: 37336719
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Risk Factor Analysis for Type 2 Diabetes Mellitus Patients with Nonalcoholic Fatty Liver Disease and Positive Correlation with Serum Uric Acid.
    Li YL; Xie H; Musha H; Xing Y; Mei CX; Wang HJ; Wulasihan M
    Cell Biochem Biophys; 2015 Jul; 72(3):643-7. PubMed ID: 27352181
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Non-alcoholic fatty liver disease increases the incidence rate of type 2 diabetes mellitus: a cohort study based on a rural town elderly population of southern Jiangsu].
    Shao Y; Xu JY; Lu XL; Chen J; Li T; Wang YT; Shi HT
    Zhonghua Gan Zang Bing Za Zhi; 2021 Sep; 29(9):867-872. PubMed ID: 34638206
    [No Abstract]   [Full Text] [Related]  

  • 28. Effect of Alcohol Consumption on Survival in Nonalcoholic Fatty Liver Disease: A National Prospective Cohort Study.
    Hajifathalian K; Torabi Sagvand B; McCullough AJ
    Hepatology; 2019 Aug; 70(2):511-521. PubMed ID: 30125379
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nonalcoholic Fatty Liver Disease and Risk of Diabetes: A Prospective Study in China.
    Shen X; Cai J; Gao J; Vaidya A; Liu X; Li W; Chen S; Zhou Y; Li Y; Zhang Y; Zhao J; Hu FB; Wu S; Gao X
    Endocr Pract; 2018 Sep; 24(9):823-832. PubMed ID: 29975579
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Body mass index and cancer incidence:a prospective cohort study in northern China].
    Guo L; Li N; Wang G; Su K; Li F; Yang L; Ren J; Chang S; Chen S; Wu S; He J; Dai M
    Zhonghua Liu Xing Bing Xue Za Zhi; 2014 Mar; 35(3):231-6. PubMed ID: 24831616
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Body Fat Distribution and Risk of Incident and Regressed Nonalcoholic Fatty Liver Disease.
    Kim D; Chung GE; Kwak MS; Seo HB; Kang JH; Kim W; Kim YJ; Yoon JH; Lee HS; Kim CY
    Clin Gastroenterol Hepatol; 2016 Jan; 14(1):132-8.e4. PubMed ID: 26226099
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Abdominal obesity, chronic inflammation and the risk of non-alcoholic fatty liver disease.
    Zhao D; Cui H; Shao Z; Cao L
    Ann Hepatol; 2023; 28(4):100726. PubMed ID: 35636732
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improvement of Nonalcoholic Fatty Liver Disease Reduces the Risk of Type 2 Diabetes Mellitus.
    Cho HJ; Hwang S; Park JI; Yang MJ; Hwang JC; Yoo BM; Lee KM; Shin SJ; Lee KJ; Kim JH; Cheong JY; Cho SW; Kim SS
    Gut Liver; 2019 Apr; 13(4):440-449. PubMed ID: 30970431
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Risk factors of gout in Jinchang cohort: a Cox regression analysis].
    He CL; Cheng N; Rong YM; Li HY; Li JS; Ding J; Hu XB; Pu HQ; Ren XW; Bai YN
    Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Jul; 38(7):897-901. PubMed ID: 28738462
    [No Abstract]   [Full Text] [Related]  

  • 35. [Association between physical exercise and non-alcoholic fatty liver disease in people infected with hepatitis B virus].
    Cai HL; Du ZC; Wang Y; Zhu SM; Li JH; Zhang WJ; Gu J; Hao YT
    Zhonghua Liu Xing Bing Xue Za Zhi; 2023 Mar; 44(3):445-451. PubMed ID: 36942340
    [No Abstract]   [Full Text] [Related]  

  • 36. The visceral adiposity index is a predictor of incident nonalcoholic fatty liver disease: A population-based longitudinal study.
    Okamura T; Hashimoto Y; Hamaguchi M; Obora A; Kojima T; Fukui M
    Clin Res Hepatol Gastroenterol; 2020 Jun; 44(3):375-383. PubMed ID: 32434704
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlation of blood glucose, serum chemerin and insulin resistance with NAFLD in patients with type 2 diabetes mellitus.
    Zhang Z; Wang J; Wang H
    Exp Ther Med; 2018 Mar; 15(3):2936-2940. PubMed ID: 29456698
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epidemiological, clinical, and biochemical characteristics of Saudi patients with nonalcoholic fatty liver disease: a hospital-based study.
    Al-hamoudi W; El-Sabbah M; Ali S; Altuwaijri M; Bedewi M; Adam M; Alhammad A; Sanai F; Alswat K; Abdo A
    Ann Saudi Med; 2012; 32(3):288-92. PubMed ID: 22588441
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Associations between dietary total antioxidant capacity and odds of non-alcoholic fatty liver disease (NAFLD) in adults: a case-control study.
    Sohouli MH; Fatahi S; Sayyari A; Olang B; Shidfar F
    J Nutr Sci; 2020; 9():e48. PubMed ID: 33244400
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dairy products intake and prevalence, incidence, and recovery of non-alcoholic fatty liver disease in Chinese population.
    Xu Y; Wang Y; Zhao Q; Chen B; Wang N; Zhang T; Jiang Y; Wu Y; He N; Zhao G; Liu X
    Hepatol Int; 2024 Apr; 18(2):529-539. PubMed ID: 38409495
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.